| Proteogenomic analysis of protein sequence alterations in breast cancer cells IM Lazar, A Karcini, S Ahuja, C Estrada-Palma Scientific reports 9 (1), 10381, 2019 | 24 | 2019 |
| The SKBR3 cell-membrane proteome reveals telltales of aberrant cancer cell proliferation and targets for precision medicine applications A Karcini, IM Lazar Scientific Reports 12 (1), 10847, 2022 | 11 | 2022 |
| Preferential phosphatidylinositol 5-phosphate binding contributes to a destabilization of the VHS domain structure of Tom1 W Xiong, TX Tang, E Littleton, A Karcini, IM Lazar, DGS Capelluto Scientific Reports 9 (1), 10868, 2019 | 4 | 2019 |
| The Cell Membrane Proteome of the SKBR3/HER2+ Cells and Implications for Cancer Targeted Therapies A Karcini Virginia Tech, 2023 | 1 | 2023 |
| Mapping the cell-membrane proteome of the SKBR3/HER2+ cell line to the cancer hallmarks IM Lazar, A Karcini, JRS Haueis Plos one 17 (8), e0272384, 2022 | 1 | 2022 |
| Proteomic Assessment of SKBR3/HER2+ Breast Cancer Cellular Response to Lapatinib and Investigational Ipatasertib Kinase Inhibitors A Karcini, NR Mercier, IM Lazar bioRxiv, 2024 | | 2024 |
| Characterization of chromosomal mutations in human embryonic stem cells that fail to differentiate A Karcini WORCESTER POLYTECHNIC INSTITUTE, 2017 | | 2017 |
| Proteomic Assessment of SKBR3/HER2+ Breast Cancer Cellular Response to Lapatinib and Investigational Ipatasertib Kinase Inhibitors IM Lazar, A Karcini, NR Mercier Frontiers in Pharmacology 15, 1413818, 0 | | |
